Modelling and simulation of redistribution of dabigatran after elimination by hemodialysis in patients with end stage renal disease

被引：0
|
作者：
Liesenfeld, K-H [1 ]
Lehr, T. [1 ]
Moschetti, V [2 ]
Formella, S. [3 ]
Clemens, A. [3 ]
Staab, A. [1 ]
Haertter, S. [1 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Translat Med, Biberach, Germany
[2] Boehringer Ingelheim Pharma GmbH & Co KG, Translat Med, Ingelheim, Germany
[3] Boehringer Ingelheim Pharma GmbH & Co KG, Global Med Affairs, Ingelheim, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-WE-247
引用
收藏
页码：597 / 598
页数：2
相关论文
共 50 条
  • [31] Pulmonary hypertension in patients with end stage renal disease undergoing hemodialysis
    Tudoran, M.
    Ciocarlie, T.
    Mates, A.
    Pescariu, S. A.
    AbuAwwad, A.
    Tudoran, Cristina
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2020, 23 (02) : 198 - 204
  • [32] Hemostatic changes in patients with end stage renal disease undergoing hemodialysis
    Alves Rios, Danyelle Romana
    Carvalho, Maria das Gracas
    Lwaleed, Bashir A.
    Simoes e Silva, Ana Cristina
    Gomes Borges, Karina Braga
    SantAna Dusse, Luci Maria
    CLINICA CHIMICA ACTA, 2010, 411 (3-4) : 135 - 139
  • [33] Intradialytic Administration of Daptomycin in End Stage Renal Disease Patients on Hemodialysis
    Salama, Noha N.
    Segal, Jonathan H.
    Churchwell, Mariann D.
    Patel, Jignesh H.
    Gao, Lihong
    Heung, Michael
    Mueller, Bruce A.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (07): : 1190 - 1194
  • [34] Cytokine Signature in End-Stage Renal Disease Patients on Hemodialysis
    Alves Rios, Danyelle Romana
    Pinheiro, Melina Barros
    de Oliveira Junior, Wander Valadares
    Gomes, Karina Braga
    Carvalho, Andrea Teixeira
    Martins-Filho, Olindo Assis
    Simoes e Silva, Ana Cristina
    Sant'Ana Dusse, Luci Maria
    DISEASE MARKERS, 2017, 2017
  • [35] Economic evaluation of end stage renal disease patients undergoing hemodialysis
    Suja, A.
    Anju, R.
    Anju, V.
    Neethu, J.
    Peeyush, P.
    Saraswathy, R.
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2012, 4 (02): : 107 - 111
  • [36] EPIDEMIOLOGY OF END STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIS FOR HOSPITAL READMISSIONS
    Kumar, P.
    VALUE IN HEALTH, 2014, 17 (07) : A811 - A811
  • [37] PHARMACOKINETICS OF SUNITINIB IN PATIENTS WITH SEVERE RENAL IMPAIRMENT OR END STAGE RENAL DISEASE ON HEMODIALYSIS
    Bello, C.
    Toh, M.
    Garrett, M.
    La Fargue, J.
    Ni, G.
    Khosravan, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 162 - 162
  • [38] Contingent negative variation before and after hemodialysis among patients with end-stage renal disease
    Bae, Jong Seok
    Park, Sung Sik
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 267 (1-2) : 70 - 75
  • [39] CHANGES IN CHOROIDAL THICKNESS IN AND OUTSIDE THE MACULA AFTER HEMODIALYSIS IN PATIENTS WITH END-STAGE RENAL DISEASE
    Chang, In Boem
    Lee, Jeong Hyun
    Kim, Jae Suk
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (05): : 896 - 905
  • [40] Cardiovascular Disease in Patients with End-Stage Renal Disease on Hemodialysis in a Developing Country
    Silva, Leila S. V.
    Oliveira, Rodrigo A.
    Silva Junior, Geraldo B.
    Lima, Jose Wellington O.
    Silva, Ricardo P.
    Liborio, Alexandre B.
    Daher, Elizabeth F.
    Sobrinho, Carlos Roberto R. M.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2012, 23 (02) : 262 - 266
12345